Steering Committee

NOA Co-Chairs

JZ - Committee RV - Committee
Professor John Zalcberg OAM
Head, Cancer Research Program in the School of Public Health and Preventive Medicine within the Faculty of Medicine, Nursing and Health Sciences at Monash University
Richard Vines
Chair & Chief Executive, Rare Cancers Australia; Deputy Chair, Australian Genomics Cancer Medicine Program; Co-chair, Consumer Advisory Board, Australian Genomic Health Alliance (AGHA); Director, Patient Voice Initiative

Pillar Heads

NOA believes that change comes through collaboration and it works across a number of groups that support and underpin its goals –  NOA calls those groups ‘pillars’ and they’re categorised by the shared experience of the members of the group. Pillar Heads report to the Steering Committee.

Pillar - Patients

Patient
Pillar

Pillar - Patient Group

Patient Group
Pillar

Pillar - Clinicians

Clinician
Pillar

Pillar - Industry

Industry
Pillar

TBA Peter Orchard
CEO, CanTeen
Prof. Clare Scott
Walter + Eliza Hall Institute of Medical Research


Prof. David Thomas
NHMRC Principal Research Fellow, Director, Kinghorn Cancer Centre and Head of the Cancer Division, Garvan Institute of Medical Research

Liz Chatwin
Country President, AstraZeneca

Steering Committee

  • Liz Chatwin – Country Manager, AstraZeneca
  • Bruce Goodwin – Managing Director, Janssen
  • Jane Kerr – General Manager, Thoracic Cancers & Rare Lung Disease, Lung Foundation
  • Barrie Littlefield – Head of Engagement, Cure Brain Cancer Foundation
  • Jonathan Pincus – Patient advocate
  • Peter Orchard – CEO, CanTeen
  • Nicola Richards – Executive Director, Market Access & Public Affairs, MSD
  • Professor Clare Scott – Walter + Eliza Hall Institute of Medical Research
  • Professor David Thomas – NHMRC Principal Research Fellow, Director, Kinghorn Cancer Centre and Head of the Cancer Division, Garvan Institute NSWGarvan Institute of Medical Research

Pillar Symbols designed by Vecteezy.com